Medical devices

Global Wearable Medical Devices Market to 2026: Focus on Activity Monitors/Trackers, Smartwatches, Patches, & Smart Clothing - ResearchAndMarkets.com

Retrieved on: 
Friday, July 30, 2021

The Global Wearable Medical Devices Market is driven by the growing geriatric population which is susceptible to various chronic diseases such as diabetes, cardiovascular diseases, cancer, among others.

Key Points: 
  • The Global Wearable Medical Devices Market is driven by the growing geriatric population which is susceptible to various chronic diseases such as diabetes, cardiovascular diseases, cancer, among others.
  • The Global Wearable Medical Devices Market is segmented based on product type, type, purpose, site, application, distribution channel, business segment, company and region.
  • Regionally, the wearable medical devices market has been segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.
  • Company Profiles: Detailed analysis of the major companies present in the Global Wearable Medical Devices Market.

Insights on the Pedicle Screw System Global Market to 2027 - Featuring Alphatec Spine, Medtronic and Stryker Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, July 30, 2021

The "Pedicle Screw System - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pedicle Screw System - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Polyaxial, one of the segments analyzed in the report, is projected to record a 6.4% CAGR and reach US$436.4 Million by the end of the analysis period.
  • The U.S. Market is Estimated at $156.9 Million, While China is Forecast to Grow at 9.5% CAGR
    The Pedicle Screw System market in the U.S. is estimated at US$156.9 Million in the year 2020.
  • In the global Other Product Types segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment.

Global Hernia Mesh Devices Industry (2020 to 2027) - Key Market Trends and Drivers - ResearchAndMarkets.com

Retrieved on: 
Friday, July 30, 2021

The "Hernia Mesh Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hernia Mesh Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Hernia Mesh Devices estimated at US$4.2 Billion in the year 2020, is projected to reach a revised size of US$5.2 Billion by 2027, growing at a CAGR of 3% over the analysis period 2020-2027.
  • The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 4.7% CAGR
    The Hernia Mesh Devices market in the U.S. is estimated at US$1.1 Billion in the year 2020.
  • In the global Other Hernia Types segment, USA, Canada, Japan, China and Europe will drive the 2.4% CAGR estimated for this segment.

Insights on the Medical Device Validation and Verification Global Market to 2027 - Featuring Charles River, Eurofins Scientific and Intertek Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, July 30, 2021

The "Medical Device Validation and Verification - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Medical Device Validation and Verification - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Mechanical Testing, one of the segments analyzed in the report, is projected to record a 9.1% CAGR and reach US$382 Million by the end of the analysis period.
  • The U.S. Market is Estimated at $139.6 Million, While China is Forecast to Grow at 12.9% CAGR
    The Medical Device Validation and Verification market in the U.S. is estimated at US$139.6 Million in the year 2020.
  • In the global EMC / ECI segment, USA, Canada, Japan, China and Europe will drive the 9.3% CAGR estimated for this segment.

Global Blood Glucose Monitoring Market Report 2021-2025 - Market is Expected to Increase at a CAGR of 13.8% - ResearchAndMarkets.com

Retrieved on: 
Friday, July 30, 2021

The "Diabetes Management: Blood Glucose Monitoring Devices Market (2021)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Diabetes Management: Blood Glucose Monitoring Devices Market (2021)" report has been added to ResearchAndMarkets.com's offering.
  • The burgeoning global blood glucose monitoring market is expected to increase at a healthy CAGR of 13.8%, from nearly $9.1bn in 2019, $9.8bn in 2020, to an estimated $19.7bn in 2025.
  • The blood glucose monitoring devices market includes: conventional handheld blood glucose meters (BGMs) that require frequent fingersticks, and new, sensor-based continuous glucose monitoring systems (CGMs) typically worn the upper arm or abdomen that conveniently monitor blood glucose 24/7, as well as lucrative supplies and software/accessories.
  • This comprehensive medical market and technology report provides:
    In-depth market and competitive analyses (market drivers/limiters, 6-year market forecasts by segment and region, 2019 and 2020 global/regional market share)

Global Market for Contract Manufacturing of Medical Devices: 2019 and 2020 Data with CAGR through 2025 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 30, 2021

The "Contract Manufacturing of Medical Devices: Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Contract Manufacturing of Medical Devices: Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • The market for contract manufacturing of medical devices is a growing market globally, with ample potential stemming from the advancement of the technology and continuous demand for medical devices.
  • This report will focus on the types of services provided by the market, such as device development and manufacturing, quality management, and assembly services.
  • For market estimates, data have been provided for 2019 (the base year), for 2020 and for 2025 (market projections).

Stryker Sponsors the PGA TOUR’s 2021 World Golf Championships-FedEx St. Jude Invitational and Educates Fans on Joint Health

Retrieved on: 
Friday, July 30, 2021

Stryker, one of the worlds leading medical technology companies, announced today that it will be a top 20 sponsor of the 2021 World Golf Championships-FedEx St. Jude Invitational.

Key Points: 
  • Stryker, one of the worlds leading medical technology companies, announced today that it will be a top 20 sponsor of the 2021 World Golf Championships-FedEx St. Jude Invitational.
  • Were excited to welcome Stryker and their Memphis-based foot and ankle business to the WGC-FedEx St. Jude Invitational, said Erin Stone, WGC-FedEx St. Jude Invitational tournament director.
  • Fans can stop by The Hub onsite at the tournament to learn more about joint health from the Stryker team through this interactive exhibit.
  • About the World Golf Championships-FedEx St. Jude Invitational
    The City of Memphis has held a PGA TOUR event every year since 1958, and 2021 will mark Memphis third year hosting a World Golf Championships event.

Owens & Minor Declares 3rd Quarter 2021 Dividend

Retrieved on: 
Friday, July 30, 2021

Owens & Minor, Inc. (NYSE: OMI) today announced that its Board of Directors have approved a third quarter 2021 dividend payment of $0.0025 per share, payable on September 30, 2021, to shareholders of record as of September 15, 2021.

Key Points: 
  • Owens & Minor, Inc. (NYSE: OMI) today announced that its Board of Directors have approved a third quarter 2021 dividend payment of $0.0025 per share, payable on September 30, 2021, to shareholders of record as of September 15, 2021.
  • A vertically-integrated, predominantly Americas-based footprint enables Owens & Minor to reliably supply its self-manufactured surgical and PPE products.
  • Operating continuously since 1882 from its headquarters in Richmond, Virginia, Owens & Minor has grown into a FORTUNE 500 company with operations located across North America, Asia, Europe and Latin America.
  • For more information about Owens & Minor, visit owens-minor.com, follow @Owens_Minor on Twitter and connect on LinkedIn at www.linkedin.com/company/owens-&-minor .

Innovative Community Oncology Practices Selects Deep Lens’ VIPER™ as Preferred Clinical Trial Matching Solution for Network

Retrieved on: 
Friday, July 30, 2021

Deep Lens and the Innovative Community Oncology Practices ( ICOP ) today announced a strategic partnership that will position Deep Lens VIPER as the preferred clinical trial program management technology solution for the 13-practice, U.S.-based network.

Key Points: 
  • Deep Lens and the Innovative Community Oncology Practices ( ICOP ) today announced a strategic partnership that will position Deep Lens VIPER as the preferred clinical trial program management technology solution for the 13-practice, U.S.-based network.
  • VIPER is an artificial intelligence-based solution that matches eligible patients to clinical trials right at the time of diagnosis.
  • Through this agreement, VIPER and other Deep Lens services will become available to all ICOP practices.
  • Innovative Community Oncology Practices (ICOP) is a conglomerate of 13 oncology practices nationwide designed to increase the scope of services and activities in the community oncology setting.

AtriCure to Participate at the Canaccord 41st Annual Growth Conference

Retrieved on: 
Friday, July 30, 2021

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming Canaccord 41st Annual Growth Conference.

Key Points: 
  • AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming Canaccord 41st Annual Growth Conference.
  • Interested parties may access a live and archived audio webcast of the presentation by visiting the Investors section of the companys website at https://ir.atricure.com .
  • AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions.
  • Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications.